Hangzhou Tigermed Consulting Co.,Ltd. (ASX: 300347) has announced a share repurchase transaction.
The company disclosed that on June 25, 2026, it utilized RMB 1.838 million to buy back 43,100 of its A-shares.
The repurchase price per share ranged between RMB 42.44 and RMB 42.78.